Zhejiang Wolwo Bio-Pharmaceutical Company Description

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.

The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kit; and Changdian II, a house dust mite skin prick diagnosis kit.

It also involved in the research and development of stem cells and medical artificial intelligence solutions.

The company was founded in 2002 and is headquartered in Huzhou, China.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Country	China
Founded	2002
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	1,679
CEO	Jianming He

Contact Details

Address: No. 636, Zhiyuan North Road Huzhou, 313200 China
Phone	86 57 2883 1088
Website	wolwobiotech.com

Stock Details

Ticker Symbol	300357
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100001R58
SIC Code	2834

Key Executives

Name	Position
Jianming He	General Manager
Guoqi Wang	Financial Manager and Head of Accounting Department
Lu Zhang	Deputy GM and Non-Independent Director
Ziqiang Bi	Deputy GM and Non-Independent Director
Zhenwei Guan	Deputy GM and Secretary of the Board of Directors
Long Ji	Deputy Manager of the Marketing Department and Employee Representative Supervisor